Sigma Investment Counselors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.58M | Hold |
1,315
| – | – | 0.08% | 97 |
|
|
2026
Q1 | $1.21M | Sell |
1,315
-45
| -3% | -$45.6K | 0.06% | 104 |
|
|
2025
Q4 | $1.46M | Sell |
1,360
-4
| -0.3% | -$3.83K | 0.07% | 100 |
|
|
2025
Q3 | $1.04M | Sell |
1,364
-273
| -17% | -$203K | 0.05% | 108 |
|
|
2025
Q2 | $1.28M | Buy |
1,637
+383
| +31% | +$298K | 0.07% | 99 |
|
|
2025
Q1 | $1.04M | Sell |
1,254
-64
| -5% | -$53.3K | 0.06% | 103 |
|
|
2024
Q4 | $1.02M | Sell |
1,318
-23
| -2% | -$19K | 0.06% | 103 |
|
|
2024
Q3 | $1.19M | Buy |
1,341
+116
| +9% | +$104K | 0.07% | 96 |
|
|
2024
Q2 | $1.11M | Sell |
1,225
-45
| -4% | -$36K | 0.07% | 97 |
|
|
2024
Q1 | $988K | Sell |
1,270
-925
| -42% | -$658K | 0.06% | 102 |
|
|
2023
Q4 | $1.28M | Sell |
2,195
-33
| -1% | -$19.3K | 0.09% | 95 |
|
|
2023
Q3 | $1.2M | Buy |
2,228
+74
| +3% | +$38.1K | 0.09% | 95 |
|
|
2023
Q2 | $1.01M | Sell |
2,154
-55
| -2% | -$23.1K | 0.07% | 98 |
|
|
2023
Q1 | $759K | Sell |
2,209
-55
| -2% | -$18.5K | 0.06% | 106 |
|
|
2022
Q4 | $828K | Buy |
2,264
+149
| +7% | +$52.8K | 0.07% | 100 |
|
|
2022
Q3 | $684K | Sell |
2,115
-35
| -2% | -$11.1K | 0.06% | 107 |
|
|
2022
Q2 | $697K | Buy |
2,150
+59
| +3% | +$17.7K | 0.06% | 106 |
|
|
2022
Q1 | $599K | Sell |
2,091
-31
| -1% | -$7.98K | 0.04% | 120 |
|
|
2021
Q4 | $586K | Buy |
2,122
+81
| +4% | +$20.5K | 0.04% | 123 |
|
|
2021
Q3 | $472K | Sell |
2,041
-120
| -6% | -$29.6K | 0.04% | 129 |
|
|
2021
Q2 | $496K | Hold |
2,161
| – | – | 0.04% | 125 |
|
|
2021
Q1 | $404K | Sell |
2,161
-200
| -8% | -$39.1K | 0.03% | 132 |
|
|
2020
Q4 | $399K | Buy |
2,361
+761
| +48% | +$114K | 0.03% | 131 |
|
|
2020
Q3 | $237K | Sell |
1,600
-271
| -14% | -$41.9K | 0.05% | 110 |
|
|
2020
Q2 | $307K | Hold |
1,871
| – | – | 0.03% | 126 |
|
|
2020
Q1 | $260K | Hold |
1,871
| – | – | 0.03% | 128 |
|
|
2019
Q4 | $246K | Sell |
1,871
-11
| -0.6% | -$1.27K | 0.03% | 142 |
|
|
2019
Q3 | $210K | Sell |
1,882
-32
| -2% | -$3.56K | 0.02% | 152 |
|
|
2019
Q2 | $212K | Buy |
1,914
+32
| +2% | +$3.77K | 0.02% | 151 |
|
|
2019
Q1 | $244K | Hold |
1,882
| – | – | 0.03% | 133 |
|
|
2018
Q4 | $218K | Buy |
1,882
+15
| +0.8% | +$1.68K | 0.03% | 131 |
|
|
2018
Q3 | $200K | Buy |
+1,867
| New | +$187K | 0.02% | 147 |
|
Other funds holding LLY
Sigma Investment Counselors's LLY Position: Q2 2026 in Review
Sigma Investment Counselors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,315 shares worth $1.58M. The position accounts for 0.08% of the portfolio, ranked #97.
Sigma Investment Counselors first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sigma Investment Counselors held 1,315 shares of Eli Lilly worth $1.58M as of Q2 2026.
- Sigma Investment Counselors left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 0.08% of Sigma Investment Counselors's portfolio in Q2 2026, its #97 holding.
- Sigma Investment Counselors first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sigma Investment Counselors's 13F filing for Q2 2026, filed 28 Jul 2026.